Inhibitory Effects of Human Serum Albumin-conjugated Superoxide Dismutase Mimetic on Breast Cancer Cell Proliferation
By Jenny Jin
Cancer is a very elusive subject; my textbooks would often place approach the topic with a disclaimer that our knowledge of cancer was evolving. And through this, I became aware that though the collection of data itself is rigorous and exact, the actual formation of hypotheses and methods to test them is an unsure process. Specifically, the results we receive can be surprising and, at times, disappointing. I had many trips in the road during my first official laboratory experience. Learning the basic research techniques as well as the process of documenting everything made me feel again like a baby learning to walk … Breast cancer continues to be one of the most prevalent of cancers, acting as the leading cause of cancer-related death for women worldwide (DeSantis et al., 2015); current treatments of breast cancer include surgery, radiotherapy, and medication. In this study, a novel drug that targets the tumor by inhibiting cell proliferation is being examined. One of the hallmarks of cancer is unlimited proliferation. Cancer cells ignore signals that in normal cells maintain a consistent balance of growth and replication (Hanahan and Weinberg, 2011). This developing treatment, by inhibiting cell proliferation, is ridding breast cancer cells of a key factor and facilitating possible clearance of the tumor cells …